For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

8 June 2006
Professor Lloyd Sansom, Chair of the Pharmaceutical Benefits Advisory Committee today presented on the issue of ‘informing benefits and harms’ and argued for the need to ensure that information relating to decisions by regulatory authorities for registration and subsidy of medicines should be freely available in the public domain.
“All the information that is considered relevant by the user should be available in an easily accessible and in an understandable format. This is a fundamental right which should not be challenged” said Professor Sansom speaking at the 2006 National Medicines Symposium in Canberra today.
Any information about registration should be in the public domain. This information should include information on the clinical trials, evaluation and registration, subsidy, post-marketing surveillance and clinical guidelines.
The information must also be freely accessible to down-stream providers including drug information resources such as the Australian Medicines Handbook and National Prescribing Service, prescribing software and decision support systems, dispensing systems, and developers of clinical guidelines.
Professor Sansom acknowledged that Public Summary Documents have begun to provide greater information however this information isn’t presented in a format that is useful for consumers. He also acknowledged that Consumer Medicine Information (CMI) is a useful tool but is not being used hence there is a need to build on this resource.
“The ultimate aim should be a central repository of all relevant information for all medicines available in Australia. Providing information is a fundamental responsibility of health professionals, media, industry and governments and needs to be presented in a format that is accessible to the end user” Professor Sansom concluded.
The 2006 National Medicines Symposium continues tomorrow.
The National Medicines Symposium is a biennial event hosted by the National Prescribing Service Ltd (NPS) and the Pharmaceutical Health And Rational use of Medicines (PHARM) Committee. This event showcases QUM programs and activities by all QUM and health stakeholders to demonstrate the important role QUM plays in the health of all Australians.
ENDS
NPS is an independent, non-profit organisation for Quality Use of Medicines, funded by the Australian Government Department of Health and Ageing.
Media enquiries
Contact us
Date published: 2006-06-08 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.